| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Therapeuticsmd, Inc. (TXMD) has 4 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. TXMD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 67.5K | $133.6K | - | |
| ? | 23.2K | $45.9K | - | |
| ? | 8.5K | $16.8K | - | |
| ? | 8.5K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2019 | Barlow Jane F | Director | Buy | 3,144 | $3.18 | $9,997.92 | New | |
| Aug 9, 2019 | Thompson Tommy G50 | Director | Buy | 5,000 | $3.04 | $15,200.00 | +0.7% | |
| Aug 9, 2019 | Bernick Brian | Director | Buy | 10,000 | $2.87 | $28,700.00 | +19.2% | |
| Aug 9, 2019 | Finizio Robert G | CEO | Buy | 52,405 | $2.96 | $155,118.80 | +0.3% | |
| May 13, 2019 | Thompson Tommy G50 | Director | Buy | 2,400 | $3.34 | $8,016.00 | +0.4% | |
| May 13, 2019 | Collins Cooper C. | Director | Buy | 30,000 | $3.33 | $99,870.00 | +83.3% | |
| Feb 27, 2019 | Musing Jules A. | Director | Sell | 17,400 | $5.80 | $100,920.00 | -77.7% | |
| Dec 20, 2018 | Finizio Robert G | CEO | Sale+OE | 184,910 | $3.66 | $677,107.66 | -0.5% | |
| Dec 18, 2018 | Milligan John C.K. IV | President/ Secretary | Sale+OE | 258,127 | $3.69 | $953,384.90 | -8.1% | |
| Dec 13, 2018 | Bernick Brian | Director | Sale+OE | 183,310 | $4.15 | $760,537.89 | -1.4% |